Newsylist real-time news trend intelligence
◼ Archived Health 🔮 Newsylist predicts: still trending tomorrow medium confidence — graded ✗ wrong

Japanese drugmaker Takeda's Qdenga becomes first dengue vaccine approved in India

7 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.

7sources
8articles
5velocity
+0%since first seen
46d agofirst detected

Answered

Why is "Japanese drugmaker Takeda's Qdenga becomes first dengue vaccine approved in Indi" trending?

Because 7 independent news sources published 8 articles about it in a short window — a coverage burst Newsylist classifies as a trend.

How does Newsylist measure this trend?

Newsylist scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.

Is this trend still active?

The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.

Where it stands

"Japanese drugmaker Takeda's Qdenga becomes first dengue vaccine approved in India" is generating significant coverage in the Health category, with 8 articles from 7 distinct sources tracked by Newsylist so far.

Outlets currently covering the story include Taiwan News, Medical Xpress, The Times of India and NDTV. Newsylist measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.

This brief was generated by Newsylist's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

Generated by Newsylist's extractive engine from coverage metadata only — no AI-written claims. Updated 44d ago.

Who reported it (8)

Momentum

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

5420Jul 21 17:29Jul 23 08:29 UTC

People, places & organizations

Topics

Related trends